Metabolomics: A global biochemical approach to drug response and disease

被引:503
|
作者
Kaddurah-Daouk, Rima [1 ]
Kristal, Bruce S. [2 ]
Weinshilboum, Richard M. [3 ]
机构
[1] Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, Durham, NC 27710 USA
[2] Brigham & Womens Hosp, Dept Neurosurg, Boston, MA 02115 USA
[3] Mayo Clin, Coll Med, Dept Mol Pharmacol & Expt Therapeut, Div Clin Pharmacol, Rochester, MN 55905 USA
关键词
pharmacometabolomics; metabolomic signatures; HPLC; mass spectroscopy; NMR; electrochemical array detection;
D O I
10.1146/annurev.pharmtox.48.113006.094715
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Metabolomics is the study of metabolism at the global level. This rapidly developing new discipline has important potential implications for pharmacologic science. The concept that metabolic state is representative of the overall physiologic status of the organism lies at the heart of metabolomics. Metabolomic studies capture global biochemical events by assaying thousands of small molecules in cells, tissues, organs, or biological fluids-followed by the application of informatic techniques to define metabolomic signatures. Metabolomic studies can lead to enhanced understanding of disease mechanisms and to new diagnostic markers as well as enhanced understanding of mechanisms for drug or xenobiotic effect and increased ability to predict individual variation in drug response phenotypes (pharmacometabolomics). This review outlines the conceptual basis for metabolomics as well as analytical and informatic techniques used to study the metabolome and to define metabolomic signatures. It also highlights potential metabolomic applications to pharmacology and clinical pharmacology.
引用
收藏
页码:653 / 683
页数:31
相关论文
共 50 条
  • [41] PARADOXICAL DRUG REACTIONS AND BIOCHEMICAL ANALYSIS OF HUMAN DISEASE
    ZAKIM, D
    GASTROENTEROLOGY, 1969, 57 (03) : 357 - &
  • [42] Developing an optimal approach to global drug safety
    Balkrishnan, R
    Furberg, CD
    JOURNAL OF INTERNAL MEDICINE, 2001, 250 (04) : 271 - 279
  • [43] Heart failure: a global disease requiring a global response
    Sanderson, JE
    Tse, TF
    HEART, 2003, 89 (06) : 585 - 586
  • [44] Metabolomics Analysis and Biochemical Profiling of Arsenic-Induced Metabolic Impairment and Disease Susceptibility
    Shoaib, Syed Muhammad
    Afzal, Samina
    Feezan, Ali
    Akash, Muhammad Sajid Hamid
    Nadeem, Ahmed
    Mir, Tahir Maqbool
    BIOMOLECULES, 2023, 13 (09)
  • [45] Biochemical approach to the investigation of pediatric mitochondrial disease
    Vallance, H
    PEDIATRIC AND DEVELOPMENTAL PATHOLOGY, 2004, 7 (06) : 633 - 636
  • [46] The metabolic landscape of decidua in recurrent pregnancy loss using a global metabolomics approach
    Wang, Li-Ling
    Liu, Hong
    Zhao, Si-Jia
    Shen, Li
    Xie, Ting
    Luo, Jing
    Mor, Gil
    Liao, Ai-Hua
    PLACENTA, 2021, 112 : 45 - 53
  • [47] An Isotopic Ratio Outlier Analysis Approach for Global Metabolomics of Biosynthetically Talented Actinomycetes
    Carey, Jordan
    Thanh Nguyen
    Korchak, Jennifer
    Beecher, Christopher
    de Jong, Felice
    Lane, Amy L.
    METABOLITES, 2019, 9 (09)
  • [48] Biochemical mechanisms of nephrotoxicity: application for metabolomics
    Niemann, Claus U.
    Serkova, Natalie J.
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2007, 3 (04) : 527 - 544
  • [49] Incorporating Other Data in GWAS Studies of Psychotropic Drug Response: Bioinformatics and Metabolomics
    van den Oord, Edwin J. C. G.
    BIOLOGICAL PSYCHIATRY, 2011, 69 (09) : 118S - 118S
  • [50] What about the herb? A new metabolomics approach for synthetic cannabinoid drug testing
    Bijlsma, Lubertus
    Gil-Solsona, Ruben
    Hernandez, Felix
    Vicente Sancho, Juan
    ANALYTICAL AND BIOANALYTICAL CHEMISTRY, 2018, 410 (21) : 5107 - 5112